Home Blog

Blog

Pharma Marketing Blog

Random

What’s Right Rx for Pharma Industry’s Survival?

Pharma Guy - April 5, 2012

Elitist Pharmaceutical Marketing

Pharma Guy - January 7, 2011

Twitter for Brands: Beyond Marketing

Pharma Guy - August 28, 2009

The Zubillaga Affair: Effect on the Prospects for Pharma Blogging

Pharma Guy - April 9, 2007

Unintended Consequences of FDA Warnings: Lilly-funded Antidepressant Case Study

Pharma Guy - June 2, 2009

Who Reads Pharma Marketing Blog?

Pharma Guy - December 19, 2007

DTC – Best of Times, Worst of Times

Pharma Guy - July 1, 2005

Et Tu, Amgen? Blincyto’s Bling! Bling! Price Tag!

Pharma Guy - December 18, 2014

ACCME’s Dirty Little Commercial Funding “Secret”

Pharma Guy - May 10, 2011

Bad Journalism or Bad Pharma?

Pharma Guy - February 10, 2012

12 3...241 Page 1 of 241

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

From Messaging to Meaning: Why Pharma Marketing Needs a Stronger Point...

April 17, 2026

Stopwatch with pharmaceutical products and analytics dashboard representing speed in pharma marketing

The Velocity Problem: When Pharma Marketing Moves Slower Than the Market

April 17, 2026

Pharmaceutical marketing concept showing hidden stakeholders like policymakers, media, and algorithms influencing healthcare decisions

Invisible Audiences: The Stakeholders Pharma Marketing Ignores at Its Own Risk

April 16, 2026